Humoral and cell-mediated immunity to Vero cell-derived influenza vaccine

By Bruhl P.   Kerschbaum A.   Kistner O.   Barrett N.   Dorner F.   Gerencer M.  

Vaccine, Vol. 19, Iss. 9, 2000-12 ,pp. : 1149-1158

Elsevier

Access to resources Recommend Favorite

Recombinant vaccine against hepatitis E: duration of protective immunity in rhesus macaques

By Zhang M.   Emerson S.U.   Nguyen H.   Engle R.   Govindarajan S.   Blackwelder W.C.   Gerin J.   Purcell R.H.  

Vaccine, Vol. 20, Iss. 27, 2002-09 ,pp. : 3285-3291

Elsevier

Access to resources Recommend Favorite

Immunity to avian pneumovirus infection in turkeys following in ovo vaccination with an attenuated vaccine

By Worthington K.J.   Sargent B.A.   Davelaar F.G.   Jones R.C.  

Vaccine, Vol. 21, Iss. 13, 2003-03 ,pp. : 1355-1362

Elsevier

Access to resources Recommend Favorite

A novel influenza subunit vaccine composed of liposome-encapsulated haemagglutinin/neuraminidase and IL-2 or GM-CSF. I. Vaccine characterization and efficacy studies in mice

By Babai I.   Samira S.   Barenholz Y.   Zakay-Rones Z.   Kedar E.  

Vaccine, Vol. 17, Iss. 9, 1999-03 ,pp. : 1223-1238

Elsevier

Access to resources Recommend Favorite

A randomized, placebo-controlled trial of subcutaneous administration of GM-CSF as a vaccine adjuvant: effect on cellular and humoral immune responses

By Somani J.   Lonial S.   Rosenthal H.   Resnick S.   Kakhniashvili I.   Waller E.K.  

Vaccine, Vol. 21, Iss. 3, 2002-12 ,pp. : 221-230

Elsevier

Access to resources Recommend Favorite